What you should know:
– Little healtha pioneer in at-home gut microbiome testing for babies, today announced the successful closing of an $8.5 million Series A funding round.
– Directed by Spéro Venturesthis round brings Tiny Health’s total funding to $13 million, furthering the company’s mission to revolutionize gut health innovation and address the growing pediatric chronic disease crisis.
Fighting a national crisis
The United States faces a pediatric chronic disease crisis, with more than 40% of children suffering from at least one of these conditions, including eczema, asthma, diabetes, obesity and food allergies . This number is constantly increasing, putting immense pressure on families and healthcare systems.
A mother’s mission, a business vision
Founded in 2020 by a mother seeking to cure her child’s gut health issues, Tiny Health draws on the expertise of microbiologists, pediatricians and scientists. Their state-of-the-art at-home tests provide:
– Comprehensive analyzes of the intestinal and vaginal microbiome
– Concrete recommendations to optimize intestinal health and remedy imbalances
– Detection of more than 120,000 microbes* using shotgun metagenomic sequencing, the most advanced technology available
Tiny Health now offers testing for adults, children (ages 3-17), and vaginal health, addressing microbiome health across all stages of life. Tiny Health conducts IRB-approved clinical studies to evaluate the effectiveness of its tests in improving health outcomes, particularly for mothers and infants.
